Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures? | Zendy

Tülay Kamaşak | Zendy; Süleyman Türedi | Zendy; Hepsen Mine Serin | Zendy; Ahmet Menteşe | Zendy; Abdülkadır Gündüz | Zendy; Ahmet Alver | Zendy; Ali Cansu | Zendy

AI Assistant Blog Pricing

Open Access

Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?

Author(s) -

Tülay Kamaşak,

Süleyman Türedi,

Hepsen Mine Serin,

Ahmet Menteşe,

Abdülkadır Gündüz,

Ahmet Alver,

Ali Cansu

Publication year - 2017

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-1504-105

Subject(s) - ischemia modified albumin , medicine , epilepsy , albumin , anesthesia , hypoxia (environmental) , pediatrics , ischemia , myocardial ischemia , psychiatry , oxygen , organic chemistry , chemistry

In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog